NRSNW

NASD NeuroSense Therapeutics Ltd. - Warrant
Nov 6, 2026 · 11:54 AM ET DELAYED Market Open

$0.0100 ↑ +0.0047 (+88.68%) Trading Up from the previous close of $0.0053, and at the day’s high of $0.0140

YTD change
-97.06%
vs 20-day SMA
-56.34%
vs 200-day SMA
N/A

Price ranges

Previous day
$0.0053 $0.0075
open $0.0075 close $0.0053
-$0.0022 (-29.33%)
Today
$0.0100 $0.0140
open $0.0110 now $0.0100
-$0.0010 (-9.09%)
Past week
$0.0053 $0.0130
from $0.0067 now $0.0100
+$0.0033 (+49.25%)
Past month
$0.0011 $0.0900
from $0.0443 now $0.0100
-$0.0343 (-77.43%)
This year
$0.0011 $0.4015
from $0.3400 now $0.0100
-$0.3300 (-97.06%)

Price & Performance

-0.10 (-94.73%) / 6M

$-0.0103$0.0652$0.1408$0.2163May 11Aug 17Nov 5

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 98.2% away from all-time highs of $0.5445
  • NRSNW is down 97% since the beginning of the year
  • NRSNW is down 97% over the past 12 months
  • NRSNW is down 77% over the past 1 month

NRSNW reads not so good: the 12-month move is -99.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A

Balance sheet & scale

IncomeN/A
RevenueN/A
CashN/A
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap N/A

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $902.90 -2.98%
IQV IQVIA Holdings Inc $264.88 +0.41%
ICLR ICON Plc $201.65 -0.72%
CRL Charles River Laboratories International, Inc. $313.02 -4.07%
IT Gartner, Inc. $198.07 -4.40%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.